MWNA
QNCX icon

Marshall Wace North America’s Quince Therapeutics QNCX Stock Holding History

Marshall Wace North America’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$9.88M Buy
539
+260
+93% +$4.14M 0.04% 356
2021
Q2 		$2.95M Buy
+279
New +$2.34M 0.01% 694
2021
Q1 		– Sell
-266
Closed -$1.48M – 1727
2020
Q4 		$1.48M Buy
266
+56
+27% +$496K 0.01% 837
2020
Q3 		$2.1M Sell
210
-86
-29% -$782K 0.01% 568
2020
Q2 		$2.74M Buy
296
+108
+57% +$990K 0.02% 501
2020
Q1 		$1.72M Sell
188
-330
-64% -$3.26M 0.01% 514
2019
Q4 		$5.81M Buy
+518
New +$3.12M 0.03% 365

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return